COBRA-Reduce – Cobra PzF Stenting to Reduce the Duration of Triple Therapy in Patients Treated with Oral Anticoagulation Undergoing Percutaneous Coronary Intervention

REVACEPT, A NOVEL INHIBITOR OF PLATELET ADHESION IN PATIENTS WITHSTABLE CORONARY ARTERY DISEASE UNDERGOING ELECTIVEPERCUTANEOUS CORONARY INTERVENTIONS: A PHASE II, MULTICENTRE,RANDOMISED, DOSE-FINDING, DOUBLE-BLIND AND PLACEBO-CONTROLLEDSTUDY